 | | |
| | |
| | |
|||||||||||||||||||||||||||||||||||
|
Topic | |
Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic-Uremic Syndrome (HUS) |
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
| |
Schistocytes |
photo size: small | high
| |
||
| |
Return to Topic | |
| |
||
| |
| |
| |
||
| |
||
Schistocytes (see arrows) are disrupted RBCs, which may occur in microangiopathic hemolytic anemia (including disseminated intravascular coagulation, thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome, and valvular hemolysis).
By permission of the publisher. From Tefferi A, Li C. In Atlas of Clinical Hematology. Edited by JO Armitage. Philadelphia, Current Medicine, 2004. Available at www.images.md.